Sonographic Evaluation of Diaphragmatic Function Under Nasal High-flow (NHF) and Non-invasive Ventilation (NIV) in Respiratory Insufficiency
SENNI
1 other identifier
interventional
35
1 country
1
Brief Summary
The aim of the study is to investigate the influence of respiratory support on diaphragmatic function (O2, NHF, NIV). The effects on the diaphragm, the respiratory values (FEV1, respiratory rate) and the subjective well-being of the patients during the therapy phases will be measured. The primary objective of the clinical study is to investigate the differences in respiratory support with regard to the change in diaphragmatic kinetics and morphology (Tdi; TEx; Tdi, ee, Tdi, pi, ΔTdi, TFdi) as a function of respiratory rate. For both ventilation modes, the influence on the respiratory situation, the respiratory muscle pump and adverse events will also be analysed. This is done using defined variables (FEV1, FEV1%VC, respiratory rate, frequency and type of adverse events (AEs), subjective satisfaction with the test product (Borg scale)).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 3, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedJuly 3, 2025
June 1, 2025
5.5 years
January 3, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sonographic measurements of diaphragm thickness
Tdi ee in mm = Diaphragm thickness is determined by measuring the distance between the diaphragmatic pleura and the diaphragm/peritoneum border at maximum expiration
after 30 minutes use
Secondary Outcomes (6)
DEx
30 minutes
FEV1
30 min
Tiffeneau - index
30 min
Respiratory rate
30 min
Tdi pi
30 minutes
- +1 more secondary outcomes
Study Arms (2)
Nasal high flow
ACTIVE COMPARATORNIV
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- acute or chronic respiratory insufficiency with and/or hypercapnia,
- age \> 18 years.
- tolerate respiratory support devices
- to sign a written declaration of consent
You may not qualify if:
- Presence of respiratory insufficiency requiring intubation,
- clinical instability,
- metabolic acidosis or alkalosis,
- Contraindication for NIV according to the S3 guideline,
- serious concomitant illnesses,
- unwillingness to co-operate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Klinikum Emdenlead
- University of Leipzigcollaborator
Study Sites (1)
University of Leipzig
Leipzig, 04103, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical director, Head of department
Study Record Dates
First Submitted
January 3, 2025
First Posted
July 3, 2025
Study Start
July 1, 2019
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
All data upon request